Cellular activation of factor IX (christmas factor)

Henry S. Kingdon, John C. Herion, P. Gregory Rausch

Research output: Contribution to journalArticle

Abstract

We have demonstrated Factor IX activation by sonicated polymorphonuclear leukocytes (PMNs). This activation reaction required the disrupted leukocytes, calcium chloride, and a small amount of normal human plasma. The requirement for normal plasma was met by plasma deficient in all of the known coagulation factors, and thus the substance present in normal plasma which facilitates this reaction was not identified. The fact that factor XI deficient plasma supported the reaction as well as normal plasma implied that factor XIa was not involved in this activation. Strontium ions could not substitute for calcium ions in the activation reaction, also implying that factor XIa was not involved. This factor IX activating principle in leukocytes could provide a mechanism for by-passing the contact factors of blood coagulation, thus providing an explanation for the discrepancy in clinical severity between deficiencies of the contact factors on the one hand and hemophilias A and B on the other.

Original languageEnglish (US)
Pages (from-to)501-507
Number of pages7
JournalThrombosis Research
Volume13
Issue number3
DOIs
StatePublished - 1978
Externally publishedYes

Fingerprint

Factor IX
Factor XIa
Blood Coagulation Factors
Leukocytes
Factor XI
Ions
Calcium Chloride
Strontium
Neutrophils
Calcium

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Hematology

Cite this

Kingdon, H. S., Herion, J. C., & Gregory Rausch, P. (1978). Cellular activation of factor IX (christmas factor). Thrombosis Research, 13(3), 501-507. https://doi.org/10.1016/0049-3848(78)90135-4

Cellular activation of factor IX (christmas factor). / Kingdon, Henry S.; Herion, John C.; Gregory Rausch, P.

In: Thrombosis Research, Vol. 13, No. 3, 1978, p. 501-507.

Research output: Contribution to journalArticle

Kingdon, HS, Herion, JC & Gregory Rausch, P 1978, 'Cellular activation of factor IX (christmas factor)', Thrombosis Research, vol. 13, no. 3, pp. 501-507. https://doi.org/10.1016/0049-3848(78)90135-4
Kingdon, Henry S. ; Herion, John C. ; Gregory Rausch, P. / Cellular activation of factor IX (christmas factor). In: Thrombosis Research. 1978 ; Vol. 13, No. 3. pp. 501-507.
@article{b54367cf5ad548f0a18781e2386ac3d7,
title = "Cellular activation of factor IX (christmas factor)",
abstract = "We have demonstrated Factor IX activation by sonicated polymorphonuclear leukocytes (PMNs). This activation reaction required the disrupted leukocytes, calcium chloride, and a small amount of normal human plasma. The requirement for normal plasma was met by plasma deficient in all of the known coagulation factors, and thus the substance present in normal plasma which facilitates this reaction was not identified. The fact that factor XI deficient plasma supported the reaction as well as normal plasma implied that factor XIa was not involved in this activation. Strontium ions could not substitute for calcium ions in the activation reaction, also implying that factor XIa was not involved. This factor IX activating principle in leukocytes could provide a mechanism for by-passing the contact factors of blood coagulation, thus providing an explanation for the discrepancy in clinical severity between deficiencies of the contact factors on the one hand and hemophilias A and B on the other.",
author = "Kingdon, {Henry S.} and Herion, {John C.} and {Gregory Rausch}, P.",
year = "1978",
doi = "10.1016/0049-3848(78)90135-4",
language = "English (US)",
volume = "13",
pages = "501--507",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Cellular activation of factor IX (christmas factor)

AU - Kingdon, Henry S.

AU - Herion, John C.

AU - Gregory Rausch, P.

PY - 1978

Y1 - 1978

N2 - We have demonstrated Factor IX activation by sonicated polymorphonuclear leukocytes (PMNs). This activation reaction required the disrupted leukocytes, calcium chloride, and a small amount of normal human plasma. The requirement for normal plasma was met by plasma deficient in all of the known coagulation factors, and thus the substance present in normal plasma which facilitates this reaction was not identified. The fact that factor XI deficient plasma supported the reaction as well as normal plasma implied that factor XIa was not involved in this activation. Strontium ions could not substitute for calcium ions in the activation reaction, also implying that factor XIa was not involved. This factor IX activating principle in leukocytes could provide a mechanism for by-passing the contact factors of blood coagulation, thus providing an explanation for the discrepancy in clinical severity between deficiencies of the contact factors on the one hand and hemophilias A and B on the other.

AB - We have demonstrated Factor IX activation by sonicated polymorphonuclear leukocytes (PMNs). This activation reaction required the disrupted leukocytes, calcium chloride, and a small amount of normal human plasma. The requirement for normal plasma was met by plasma deficient in all of the known coagulation factors, and thus the substance present in normal plasma which facilitates this reaction was not identified. The fact that factor XI deficient plasma supported the reaction as well as normal plasma implied that factor XIa was not involved in this activation. Strontium ions could not substitute for calcium ions in the activation reaction, also implying that factor XIa was not involved. This factor IX activating principle in leukocytes could provide a mechanism for by-passing the contact factors of blood coagulation, thus providing an explanation for the discrepancy in clinical severity between deficiencies of the contact factors on the one hand and hemophilias A and B on the other.

UR - http://www.scopus.com/inward/record.url?scp=0018081174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018081174&partnerID=8YFLogxK

U2 - 10.1016/0049-3848(78)90135-4

DO - 10.1016/0049-3848(78)90135-4

M3 - Article

VL - 13

SP - 501

EP - 507

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 3

ER -